DPT (Data Process Tracking) Analysis of Biopharmaceutical Companies Based on fsQCA Method of ESG System: Aiming at Improving the ESG System MES-DPT & GMP-DPT and the ESG Quantitative Indicators of the Biopharmaceutical Industry

DPT (Data Process Tracking) Analysis of Biopharmaceutical Companies Based on fsQCA Method of ESG System: Aiming at Improving the ESG System MES-DPT & GMP-DPT and the ESG Quantitative Indicators of the Biopharmaceutical Industry

In recent years, safety recalls have occurred frequently in the biopharmaceutical industry, which affects the health of consumers. This article attempts to use the fsQCA method to draw a conclusion through the study of ESG and its quantification system, as well as the study of data samples related to MES and GMP processes, that is, MES-DPT has a positive impact on process safety management, and GMP-DPT has a positive impact on process safety. Management has a positive and positive impact, and ESG-DPT has a positive and positive impact on process safety management. Finally, this article puts forward suggestions for improving ESG-DPT, MES-DPT, GMP-DPT and the biomedical ESG-DPT model. Future research hopes to further study ESG -DPT model and ESG biomedical industry indicators.